{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Alexandra", "organization": "", "rank": 1, "lastname": "STEVENSON"}, {"role": "reported", "firstname": "Matthew", "organization": "", "rank": 2, "lastname": "GOLDSTEIN"}], "original": "By ALEXANDRA STEVENSON and MATTHEW GOLDSTEIN"}, "news_desk": "Business", "slideshow_credits": null, "abstract": "Pershing Square Capital Management founder William A Ackman testifies at Senate hearing on Valeant Pharmaceuticals' drug pricing policies; his hedge fund, along with others, have lost billions of dollars on Valeant, which has seen its share price plummet 85 percent since 2015.", "multimedia": [{"type": "image", "url": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbWide.jpg", "legacy": {"wide": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/04/28/business/28DB-HERD/28DEB-HERD-articleLarge.jpg", "legacy": {"xlarge": "images/2016/04/28/business/28DB-HERD/28DEB-HERD-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "480"}, "width": 600, "subtype": "xlarge", "height": 480}, {"type": "image", "url": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"print_headline": "As Valeant Tumbles, So Does Billionaire\u2019s Hedge Fund Herd", "main": "As Valeant Tumbles, So Does Bill Ackman\u2019s Hedge Fund Herd"}, "print_page": "6", "keywords": [{"value": "Hedge Funds", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Ackman, William A", "is_major": "Y", "rank": "2", "name": "persons"}, {"value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "3", "name": "organizations"}, {"value": "Pershing Square Capital Management", "is_major": "Y", "rank": "4", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Bankruptcies", "is_major": "N", "rank": "6", "name": "subject"}], "snippet": "The crowding phenomenon comes amid a backdrop of turbulence for the hedge fund industry, where some of the biggest names have reported double-digit losses.", "source": "The New York Times", "lead_paragraph": "The crowding phenomenon comes amid a backdrop of turbulence for the hedge fund industry, where some of the biggest names have reported double-digit losses.", "word_count": "1333", "pub_date": "2016-04-28T00:00:00Z", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/04/28/business/dealbook/as-valeant-tumbles-so-does-billackmans-hedge-fund-herd.html", "_id": "57215bd738f0d83acb9a61f3"}